category,datetime,headline,id,image,related,source,summary,url
company,1768251052,44th Annual J.P. Morgan Healthcare Conference,138079653,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,BMY,SeekingAlpha,2026-01-12. The following slide deck was published by Bristol-Myers Squibb Company in conjunction with this event.,https://finnhub.io/api/news?id=44514b5ce2eba6eaa4479af62b3701e65fcac3a2263b18b8be39b7e9f97db805
company,1768242932,Tempus Shares Jump After Strong Preliminary 2025 Results,138078087,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BMY,Yahoo,Investors Eye 2026 Guidance as Tempus AI Tops $1.1B in Contract Value,https://finnhub.io/api/news?id=686979a1fb16905d5efaf87fbfd2069526ea76d5517eb4566138dbd0b9d79802
company,1768240904,"What $6,500 a Month Really Looks Like in Retirement at 67",138078048,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BMY,Yahoo,"Retiring at 67 with $6,500 in monthly income places you solidly in middle-class territory, but the financial reality behind that figure is more nuanced than it appears. With average Social Security benefits at $2,017 per month in 2026, a retiree targeting $6,500 needs to generate roughly $4,483 monthly—or $53,796 annually—from personal savings and investments. The ... What $6,500 a Month Really Looks Like in Retirement at 67",https://finnhub.io/api/news?id=6893e956b6faae41cdb1adaa3ed4f00fff9f2f71cae9fb0f95d173a221eb60ef
company,1768235880,‘Biotech Super Bowl’ Lands With a Thud. Stocks Slide on Lack of Deal News.,138076408,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BMY,Yahoo,"Monday is the first day of  J.P. Morgan’s  annual healthcare investor conference, which draws thousands of investors, analysts, and executives to San Francisco each year.  There is ample precedent: Last year,  Johnson & Johnson  announced a $14.6 billion deal to acquire Intra-Cellular Therapeutics on the first day of the gathering.  The Wall Street Journal reported last week that Merck was in talks to buy the biotech Revolution Medicines for roughly $30 billion, but as of late morning, no such agreement had been announced.",https://finnhub.io/api/news?id=a8e42fa0176125b6d61a239d1fc7e9d3ac654534ef8fe6ce6ee1a22fdfcc0ed8
company,1768232759,Bristol-Myers Squibb Company (BMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript,138078586,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,BMY,SeekingAlpha,"Bristol-Myers Squibb Company (BMY) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 10:30 AM ESTCompany ParticipantsChristopher Boerner - CEO...",https://finnhub.io/api/news?id=c048d400ccc0ba302b5226bc34d7334cd149200e52e349ce914af00b03f83c66
company,1768230722,Scotiabank Raises Bristol-Myers (BMY) PT to $60 Citing Catalyst-Rich 2026 Growth,138075306,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BMY,Yahoo,"Bristol-Myers Squibb Company (NYSE:BMY) is one of the cheap stocks to buy for the next 3 years. On January 9, Scotiabank analyst Louise Chen raised the firm’s price target on Bristol-Myers to $60 from $53, while maintaining a Sector Perform rating on the shares. With the stock trading at an inexpensive valuation and several key […]",https://finnhub.io/api/news?id=4d2767b0f8c5def71088d475ff2a8239c971d1dcb869260006c6afa389476248
company,1768227002,3 Top Dividend Stocks to Maximize Your Retirement Income,138075307,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BMY,Yahoo,"The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",https://finnhub.io/api/news?id=d44cbcbba852cd0762ac5f116eb17a5d12a6088a644f583eaea9f04e4aac622f
company,1768219140,Bristol Myers Squibb Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM),138071516,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,BMY,Yahoo,"PRINCETON, N.J., January 12, 2026--BMS Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos in Adolescents with Symptomatic oHCM",https://finnhub.io/api/news?id=dd9030ce5ad66def181b5cdac70ea7df5810dcae0cf82ed7cbb8b0a9d87cd8d9
